Data Collection and Evaluation of OptiBP Under Investigational Use
Launched by BIOSPECTAL · Aug 24, 2023
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to gather information to help develop and improve a mobile phone app called OptiBP, which uses advanced technology to estimate blood pressure. By participating, you'll help researchers understand how well this app works in measuring blood pressure using a smartphone.
To join the study, you need to be at least 18 years old, live in the United States, and have an Android smartphone. You'll also need an arm-worn blood pressure cuff and be comfortable using the Google Play store to download the app. Participants should be able to communicate in English and agree to take part in the study. If you have certain medical conditions, like skin allergies to nickel or serious heart rhythm issues, you may not be eligible. If you decide to participate, you can expect to use the app and share your blood pressure readings to help improve this innovative technology.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Be at least 18 years old (at least 19 years old in Alabama and Nebraska, at least 21 years old in Puerto Rico);
- • 2. Live in the United States of America
- • 3. Have an Android smartphone
- • 4. Have access to an arm-worn blood pressure monitor (cuff)
- • 5. Have access to the Google Play store to download the OptiBP study app on their phone
- • 6. Be comfortable communicating in written and spoken English
- • 7. Be willing and able to provide informed consent to participate in the study
- Exclusion Criteria:
- • 1. Known contact dermatitis to nickel/chromium
- • 2. Lesion or deficiency on hand, preventing placing a finger on the smartphone camera
- • 3. Known dysrhythmia like bigeminy, trigeminy, isolated VPB, atrial fibrillation
About Biospectal
Biospectal is an innovative healthcare technology company dedicated to transforming cardiovascular health through advanced optical sensing solutions. By leveraging cutting-edge algorithms and non-invasive measurement techniques, Biospectal aims to deliver accurate and real-time blood pressure monitoring and health insights directly from smartphones. Their commitment to enhancing patient care and empowering individuals with accessible health data positions them at the forefront of digital health advancements. Through rigorous clinical trials, Biospectal seeks to validate the efficacy of its solutions, ensuring they meet the highest standards of safety and reliability for patients and healthcare providers alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Truckee, California, United States
Patients applied
Trial Officials
Frederic Frappereau
Principal Investigator
Biospectal
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported